Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind,

Julio Vallejos1, Rodrigo Zoni2, María Bangher1

  • 1Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina.

Abstract

Insights

Ivermectin did not significantly prevent hospitalization in early COVID-19 patients. Those treated with ivermectin required invasive mechanical ventilatory support earlier than the placebo group.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Trials

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, prompted research into repurposed treatments.
  • Investigating ivermectin as a potential intervention for early-stage COVID-19 is crucial.

Purpose of the Study:

  • To evaluate the efficacy of ivermectin in preventing hospitalization among non-hospitalized COVID-19 patients.
  • To assess the safety and other efficacy endpoints of ivermectin treatment.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involving 501 non-hospitalized COVID-19 patients.
  • Patients received either ivermectin or a placebo for two days, with staggered dosing based on weight.
  • Primary outcome was hospitalization; secondary outcomes included safety and viral clearance.

Main Results:

  • No statistically significant difference in hospitalization rates between the ivermectin (5.6%) and placebo (8.4%) groups (p=0.227).
  • Patients receiving ivermectin showed a trend towards earlier need for invasive mechanical ventilatory support (5.25 days vs. 10 days, p=0.019).
  • No significant differences were observed in secondary outcomes like PCR negativity or safety.

Conclusions:

  • Ivermectin demonstrated no significant benefit in preventing hospitalization for COVID-19.
  • Early use of ivermectin may be associated with an earlier requirement for mechanical ventilation.
  • Further research is needed, considering limitations such as hospitalization event rates and population risk profiles.

Related Concept Videos

Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.6K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
32
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.0K
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.2K